MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
Mara Ten KateAlberto RedolfiEnrico PeiraIsabelle BosStephanie J VosRik VandenbergheSilvy GabelJolien SchaeverbekePhilip ScheltensOlivier BlinJill C RichardsonRegis BordetAnders WallinCarl EckerstromJosé Luis MolinuevoSebastiaan EngelborghsChristine Van BroeckhovenPablo Martinez-LageJulius PoppMagdalini TsolakiFrans R J VerheyAlison L BairdCristina Legido-QuigleyLars BertramValerija DobricicHenrik ZetterbergSimon LovestoneJohannes StrefferSilvia BianchettiGerald P NovakJerome RevillardMark F GordonZhiyong XieViktor WottschelGiovanni FrisoniPieter Jelle VisserFrederik BarkhofPublished in: Alzheimer's research & therapy (2018)
Amyloid pathology is associated with changes in structural MRI measures in CN and MCI. An automated classifier based on clinical, imaging and APOE ε4 data can identify the presence of amyloid pathology with a moderate level of accuracy. These results could be used in clinical trials to pre-screen subjects for anti-amyloid therapies.